The FDA has narrowly backed Merck’s covid pill—but it’s not that effective
MIT Technology Review -

The news: A US Food and Drug Administration panel has voted by 13 to 10 to recommend that the government authorize Merck’s antiviral pill for patients with early covid-19 who are at high risk for severe infection. The drug, called molnupiravir, has been shown to reduce the risk of hospitalization and death, although by less

Read this story at

Loading...

Related Articles